Search

Search Constraints

You searched for: Author/Creator Loglio, Alessandro

Search Results

2. The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapy. (23rd May 2020)

4. Circulating cell‐free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients. Issue 3 (16th December 2020)

5. Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir. (7th January 2019)

6. The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Issue 5 (11th October 2017)

7. Minimal increases of serum alpha‐foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long‐term oral therapy. (12th August 2019)

8. Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide. Issue 10 (October 2020)

9. Incremental value of HBcrAg to classify 1582 HBeAg‐negative individuals in chronic infection without liver disease or hepatitis. Issue 6 (19th January 2021)

10. Dual proteotoxic stress accelerates liver injury via activation of p62‐Nrf2. Issue 1 (18th March 2021)